Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Lung Cancer

  Free Subscription


07.09.2020

2 Am J Respir Crit Care Med
2 Ann Thorac Surg
5 Anticancer Res
3 BMC Cancer
1 Cancer Lett
1 Cancer Res
2 Cancer Sci
1 Clin Cancer Res
2 Clin Lung Cancer
2 Eur J Cancer
1 Eur J Cardiothorac Surg
1 Eur Respir J
1 Int J Cancer
6 J Thorac Cardiovasc Surg
3 J Thorac Oncol
1 Lancet Respir Med
2 Lung Cancer
2 N Engl J Med
1 Oncologist
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. MASSION PP, Antic S, Ather S, Arteta C, et al
    Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules.
    Am J Respir Crit Care Med. 2020;202:241-249.
    PubMed         Abstract available

  2. PISANO C, O'Connor J, Krick S, Russell DW, et al
    A Fatal Case of Pneumocephalus during Computed Tomography-guided Lung Biopsy.
    Am J Respir Crit Care Med. 2020;201:e83-e84.
    PubMed        


    Ann Thorac Surg

  3. SUN L, Dai J, Chen Y, Duan L, et al
    Pulmonary Sarcomatoid Carcinoma: Experience From SEER Database and Shanghai Pulmonary Hospital.
    Ann Thorac Surg. 2020;110:406-413.
    PubMed         Abstract available

  4. TANG A, Raja S, Bribriesco AC, Raymond DP, et al
    Robotic Approach Offers Similar Nodal Upstaging to Open Lobectomy for Clinical Stage I Non-small Cell Lung Cancer.
    Ann Thorac Surg. 2020;110:424-433.
    PubMed         Abstract available


    Anticancer Res

  5. KOBAYASHI K, Kaira K, Kagamu H
    Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer.
    Anticancer Res. 2020;40:5309-5311.
    PubMed         Abstract available

  6. HALLEY A, Leonetti A, Gregori A, Tiseo M, et al
    The Role of the Microbiome in Cancer and Therapy Efficacy: Focus on Lung Cancer.
    Anticancer Res. 2020;40:4807-4818.
    PubMed         Abstract available

  7. NONPANYA N, Prakhongcheep O, Petsri K, Jitjaicham C, et al
    Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells.
    Anticancer Res. 2020;40:4989-4999.
    PubMed         Abstract available

  8. CHEN HL, Gong JY, Lin SC, Li S, et al
    Effects of Sclareol Against Small Cell Lung Carcinoma and the Related Mechanism: In Vitro and In Vivo Studies.
    Anticancer Res. 2020;40:4947-4960.
    PubMed         Abstract available

  9. FLESCHUTZ K, Walter L, Leistner R, Heinzerling L, et al
    ALK Inhibitors Do Not Increase Sensitivity to Radiation in EML4-ALK Non-small Cell Lung Cancer.
    Anticancer Res. 2020;40:4937-4946.
    PubMed         Abstract available


    BMC Cancer

  10. BAN WH, Yeo CD, Han S, Kang HS, et al
    Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer.
    BMC Cancer. 2020;20:848.
    PubMed         Abstract available

  11. PARK HY, Hwang J, Kim DH, Jeon SM, et al
    Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea.
    BMC Cancer. 2020;20:846.
    PubMed         Abstract available

  12. WANG J, Liu Z, Pang Q, Zhang T, et al
    Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases.
    BMC Cancer. 2020;20:837.
    PubMed         Abstract available


    Cancer Lett

  13. WANG C, Tan S, Li J, Liu WR, et al
    CircRNAs in lung cancer - Biogenesis, function and clinical implication.
    Cancer Lett. 2020 Aug 26. pii: S0304-3835(20)30427.
    PubMed         Abstract available


    Cancer Res

  14. LU Y, Liu Y, Oeck S, Zhang GJ, et al
    Hypoxia induces resistance to EGFR inhibitors in lung cancer cells via upregulation of FGFR1 and the MAPK pathway.
    Cancer Res. 2020 Sep 1. pii: 0008-5472.CAN-20-1192.
    PubMed         Abstract available


    Cancer Sci

  15. ICHIKAWA A, Fujita Y, Hosaka Y, Kadota T, et al
    Chaperon-Mediated Autophagy Receptor Modulates Tumor Growth and Chemoresistance in Non-Small Cell Lung Cancer.
    Cancer Sci. 2020 Aug 28. doi: 10.1111/cas.14629.
    PubMed         Abstract available

  16. YANG L, Wang X, Jiao X, Tian B, et al
    Spt16 promotes lung cancer malignancy and is negatively regulated by miR-1227-5p.
    Cancer Sci. 2020 Aug 28. doi: 10.1111/cas.14627.
    PubMed         Abstract available


    Clin Cancer Res

  17. ORTIZ-CUARAN S, Mezquita L, Swalduz A, Aldea M, et al
    Circulating tumor DNA genomics reveals potential mechanisms of resistance to BRAF-targeted therapies in BRAF-mutant metastatic non-small cell lung cancer patients.
    Clin Cancer Res. 2020 Aug 28. pii: 1078-0432.CCR-20-1037.
    PubMed         Abstract available


    Clin Lung Cancer

  18. MANKUZHY NP, Almahariq MF, Siddiqui ZA, Thompson AB, et al
    The Role of Postoperative Radiation Therapy for pN2 Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Jul 30. pii: S1525-7304(20)30230.
    PubMed         Abstract available

  19. HALL PE, Ready N, Johnston A, Bomalaski JS, et al
    Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer.
    Clin Lung Cancer. 2020 Jul 30. pii: S1525-7304(20)30234.
    PubMed         Abstract available


    Eur J Cancer

  20. MONTRONE M, Catino A, Palmieri VO, Longo V, et al
    Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib.
    Eur J Cancer. 2020;138:109-112.
    PubMed        

  21. YANES M, Santoni G, Maret-Ouda J, Ness-Jensen E, et al
    Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study.
    Eur J Cancer. 2020;138:80-88.
    PubMed         Abstract available


    Eur J Cardiothorac Surg

  22. CORSINI EM, Weissferdt A, Pataer A, Zhou N, et al
    Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy.
    Eur J Cardiothorac Surg. 2020 Aug 30. pii: 5899328. doi: 10.1093.
    PubMed         Abstract available


    Eur Respir J

  23. GARNER JL, Shah PL
    Challenges of evaluating lung function as part of cancer care during the COVID-19 pandemic.
    Eur Respir J. 2020;56.
    PubMed        


    Int J Cancer

  24. DUDNIK E, Moskovitz M, Agbarya A, Gottfried T, et al
    Alternative nivolumab duration and scheduling in advanced non-small cell lung cancer (aNSCLC): a real-world evidence.
    Int J Cancer. 2020 Sep 1. doi: 10.1002/ijc.33281.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  25. MATTHEWS CR, Hess PJ
    Thirty-three, zero, nine.
    J Thorac Cardiovasc Surg. 2020;160:871-875.
    PubMed        

  26. CHEN KN
    Commentary: Not only safety but also efficacy is required in repeat pulmonary resection for second non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Aug 8. pii: S0022-5223(20)32360.
    PubMed        

  27. CHU NQ, Liu R, Colby A, de Forcrand C, et al
    Paclitaxel-loaded expansile nanoparticles improve survival following cytoreductive surgery in pleural mesothelioma xenografts.
    J Thorac Cardiovasc Surg. 2020;160:e159-e168.
    PubMed         Abstract available

  28. ZAMBETTI BR, Ng T
    Commentary: Patient frailty also drives long-term outcomes after R0 resection for lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 14. pii: S0022-5223(20)32079.
    PubMed        

  29. ZHANG Y, Jheon S, Li H, Zhang H, et al
    Results of low-dose computed tomography as a regular health examination among Chinese hospital employees.
    J Thorac Cardiovasc Surg. 2020;160:824-831.
    PubMed         Abstract available

  30. HATTORI A, Matsunaga T, Watanabe Y, Fukui M, et al
    Repeated anatomical pulmonary resection for metachronous ipsilateral second non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 16. pii: S0022-5223(20)32150.
    PubMed         Abstract available


    J Thorac Oncol

  31. LEE JC, Blazak JK
    The Use of Positron Emission Tomography in Coronavirus Disease 2019 Cases.
    J Thorac Oncol. 2020 May 5. pii: S1556-0864(20)30374.
    PubMed        

  32. CALABRESE F, Fortarezza F, Giraudo C, Pezzuto F, et al
    Two sorts of microthrombi in a COVID-19 patient with lung cancer.
    J Thorac Oncol. 2020 Aug 28. pii: S1556-0864(20)30668.
    PubMed        

  33. TAN AC, Seet AOL, Lai GGY, Lim TH, et al
    Molecular characterisation and clinical outcomes in RET rearranged non-small cell lung cancer (NSCLC).
    J Thorac Oncol. 2020 Aug 28. pii: S1556-0864(20)30671.
    PubMed         Abstract available


    Lancet Respir Med

  34. VENKATESAN P
    IASLC 2020 World Conference on Lung Cancer.
    Lancet Respir Med. 2020 Aug 28. pii: S2213-2600(20)30395.
    PubMed        


    Lung Cancer

  35. CHRISTOPOULOS P, Kirchner M, Roeper J, Saalfeld F, et al
    Risk stratification of EGFR(+) lung cancer diagnosed with panel-based next-generation sequencing.
    Lung Cancer. 2020;148:105-112.
    PubMed         Abstract available

  36. SUDA K, Murakami I, Obata K, Sakai K, et al
    Spatial heterogeneity of acquired resistance mechanisms to 1st/2nd generation EGFR tyrosine kinase inhibitors in lung cancer.
    Lung Cancer. 2020;148:100-104.
    PubMed         Abstract available


    N Engl J Med

  37. KURZROCK R
    Selpercatinib Aimed at RET-Altered Cancers.
    N Engl J Med. 2020;383:868-869.
    PubMed        

  38. WOLF J, Seto T, Han JY, Reguart N, et al
    Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
    N Engl J Med. 2020;383:944-957.
    PubMed         Abstract available


    Oncologist

  39. MELOSKY B, Cheema PK, Brade A, McLeod D, et al
    Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer.
    Oncologist. 2020 Aug 29. doi: 10.1634/theoncologist.2020-0193.
    PubMed         Abstract available


    PLoS One

  40. DING H, Xin W, Tong Y, Sun J, et al
    Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review.
    PLoS One. 2020;15:e0238536.
    PubMed         Abstract available

  41. SUTTON AJ, Sagoo GS, Jackson L, Fisher M, et al
    Cost-effectiveness of a new autoantibody test added to Computed Tomography (CT) compared to CT surveillance alone in the diagnosis of lung cancer amongst patients with indeterminate pulmonary nodules.
    PLoS One. 2020;15:e0237492.
    PubMed         Abstract available

  42. GOLDSBURY DE, Weber MF, Yap S, Rankin NM, et al
    Health services costs for lung cancer care in Australia: Estimates from the 45 and Up Study.
    PLoS One. 2020;15:e0238018.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: